- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 27/14 - Decongestants or antiallergics
Patent holdings for IPC class A61P 27/14
Total number of patents in this class: 300
10-year publication summary
|
14
|
20
|
16
|
13
|
23
|
18
|
9
|
11
|
11
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Santen Pharmaceutical Co., Ltd. | 593 |
16 |
| Daiichi Sankyo Company, Limited | 1890 |
8 |
| Dainippon Sumitomo Pharma Co., Ltd. | 163 |
6 |
| Glenmark Specialty S.A. | 84 |
6 |
| Senju Pharmaceutical Co., Ltd. | 223 |
6 |
| Taisho Pharmaceutical Co., Ltd. | 846 |
6 |
| AstraZeneca AB | 2823 |
4 |
| Alcon Research, Ltd. | 331 |
4 |
| Aldeyra Therapeutics, Inc. | 101 |
4 |
| Industry-Academic Cooperation Foundation, Yonsei University | 2441 |
4 |
| Novartis AG | 10169 |
3 |
| Takeda Pharmaceutical Company Limited | 2700 |
3 |
| Allakos Inc. | 46 |
3 |
| Bausch & Lomb Incorporated | 1059 |
3 |
| Ewha University-industry Collaboration Foundation | 810 |
3 |
| NTC S.r.l. | 85 |
3 |
| Shionogi & Co., Ltd. | 886 |
3 |
| Siolta Therapeutics, Inc. | 18 |
3 |
| Société des Produits Nestlé S.A. | 10044 |
2 |
| Johnson & Johnson Vision Care, Inc. | 1159 |
2 |
| Other owners | 208 |